UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China Journal article
Ruan, Zhen, Chen, Xianwen, Song, Menghuan, Jia, Ruxu, Luo, Hang, Ung, Carolina Oi Lam, Hu, Hao. Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China[J]. Diabetes, Metabolic Syndrome and Obesity, 2024, 17, 3657-3666.
Authors:  Ruan, Zhen;  Chen, Xianwen;  Song, Menghuan;  Jia, Ruxu;  Luo, Hang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.8/3.3 | Submit date:2024/11/05
Type 2 Diabetes Mellitus  Glucagon-like Peptide-1 Receptor Agonist  Glp-1ra  Retrospective  China  Electronic Medical Record  Real-world  
Acute effect of high-intensity interval training versus moderate-intensity continuous training on appetite-regulating gut hormones in healthy adults: A systematic review and meta-analysis Journal article
Mingzhu Hu, Zhaowei Kong, Qingde Shi, Jinlei Nie. Acute effect of high-intensity interval training versus moderate-intensity continuous training on appetite-regulating gut hormones in healthy adults: A systematic review and meta-analysis[J]. Heliyon, 2023, 9(2), e13129.
Authors:  Mingzhu Hu;  Zhaowei Kong;  Qingde Shi;  Jinlei Nie
Favorite | TC[WOS]:5 TC[Scopus]:4  IF:3.4/3.9 | Submit date:2023/02/22
Appetite-regulating Hormones  Ghrelin  Glucagon-like Peptide-1  Peptide Yy  Sprint Interval Training  
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China Journal article
Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China[J]. Diabetes Therapy, 2023, 14(1), 93-107.
Authors:  Liu, Lei;  Ruan, Zhen;  Ung, Carolina Oi Lam;  Zhang, Yawen;  Shen, Yang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:2.8/2.9 | Submit date:2023/01/08
Cost-effectiveness Analysis  Type 2 Diabetes  Glucagon-like Peptide-1 Analogue  Semaglutide  Peg-loxenatide  China  
The Effect of Feeding Behavior on Hypothalamus in Obese Type 2 Diabetic Rats with Glucagon-like Peptide-1 Receptor Agonist Intervention Journal article
Lu, Ke, Chen, Xiaoyan, Yan, Jianhua, Li, Xinchun, Huang, Chen, Wan, Qi, Deng, Xuelian, Zou, Qiao. The Effect of Feeding Behavior on Hypothalamus in Obese Type 2 Diabetic Rats with Glucagon-like Peptide-1 Receptor Agonist Intervention[J]. OBESITY FACTS, 2018, 11(3), 181-194.
Authors:  Lu, Ke;  Chen, Xiaoyan;  Yan, Jianhua;  Li, Xinchun;  Huang, Chen; et al.
Favorite | TC[WOS]:6 TC[Scopus]:5  IF:3.9/4.2 | Submit date:2018/10/30
Obesity  Glucagon-like Peptide-1 Receptor Agonist  Magnetic Resonance Imaging  Appetite Regulation  Hypothalamus  
Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease Journal article
Kosaraju, Jayasankar, Holsinger, R. M. Damian, Guo, Lixia, Tam, Kin Yip. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease[J]. MOLECULAR NEUROBIOLOGY, 2017, 54(8), 6074-6084.
Authors:  Kosaraju, Jayasankar;  Holsinger, R. M. Damian;  Guo, Lixia;  Tam, Kin Yip
Favorite | TC[WOS]:80 TC[Scopus]:84  IF:4.6/4.7 | Submit date:2018/10/31
Glucagon-like Peptide-1  Glucose-dependent Insulinotropic Polypeptide  Amyloid Beta  Tau Phosphorylation  Neuroinflammation  
Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease Journal article
Kosaraju, J., Holsinger, D., Guo, L., Tam, K. Y.. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer’s Disease[J]. Molecular Neurobiology, 2016, ---.
Authors:  Kosaraju, J.;  Holsinger, D.;  Guo, L.;  Tam, K. Y.
Favorite | TC[WOS]:80 TC[Scopus]:84  IF:4.6/4.7 | Submit date:2022/07/28
Glucagon-like Peptide-1  Glucose-dependent Insulinotropic Polypeptide  Amyloid Beta  Tau Phosphorylation  Neuroinflammation